Outfitting Your Practice for the Future
Of all the pandemic-induced changes, which will become part of the new normal’s modus operandi?
Featured Content
Retina
Gene Therapy for Inherited Retinal Disease
A look at the results ophthalmic researchers and companies are generating as they explore genetic therapies for these difficult-to-treat conditions.
Glaucoma
The Best Approach for Narrow-Angle Patients
The age of the patient is one of the many factors to consider when treating patients with narrow angles, experts say.
Glaucoma
The Glaucoma Medication Pipeline, 2022
Catching up on the status of four eye drops being developed to target the disease.
Practice Management
Update: Private Equity in Ophthalmology
Many surgeons say they’ve had a positive experience—but proceeding with caution is advised.
Review of Ophthalmology Online eNewsletter
- Prediction of Central VF Severity in Glaucoma
Find out the effectiveness of this strategy. Predicting Treatment Frequency of Ranibizumab Injections in DME
Find out the three main contributing factors.- Disparities in VA Outcomes after Endothelial Keratoplasty
Read about factors associated with worse VA outcomes after the procedure for Fuchs’ endothelial corneal dystrophy and bullous keratopathy. - Progression of Atrophy Between Neovascular & Non-Neovascular AMD
Researchers are learning more about macular neovascularization’s relationship to atrophy. - Industry News
Continuing Medical Education
-
Optimal Diagnosis and Treatment of Blepharoptosis
In this CME Monograph from MedEdicus, a panel of expert ophthalmologists will review the common causes of ptosis and traditional therapies for ptosis correction. The panel will also review the clinical data for oxymetazoline 0.1%, a new topical medical therapy approved for ptosis treatment. In addition, a series of cases will be discussed to demonstrate the systematic evaluation of patients with ptosis and the development of individualized treatment plans. -
A Closer Look: Emerging Medical Therapies for Presbyopia
This CME activity provides an overview of age-related loss of accommodation as well as several of the emerging topical therapies for presbyopia that are under investigation. Perspectives on selection of prospective patients as well as potential opportunities for practice growth are also discussed. -
Don't Miss Neurotrophic Keratitis: New Approaches to Assess and Treat
A panel of experts discuss the importance of early detection of neurotrophic keratitis and the latest data on available treatment options in this CME activity. -
Breaking New Ground: Reducing Treatment Burden in Neovascular AMD
This CME monograph, based on an expert roundtable discussion, will present challenging cases in nAMD along with the latest clinical trial data and perspectives on how the newest advances in nAMD treatment can be translated to the real world.
Additional Publications
-
Treatment of Proliferative Diabetic Retinopathy
Sponsored by Regeneron Setting Up Today's Cataract & Refractive Surgeons for Success
February 2022 Ophthalmic Product Guide
Taking Anterior Segment Analysis to the Next Level
EyePoint Assist: Leave Reimbursement Risk Behind
July 2021 Ophthalmic Product Guide